Does MONGERSEN Cause Product use in unapproved indication? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product use in unapproved indication have been filed in association with MONGERSEN. This represents 22.7% of all adverse event reports for MONGERSEN.
5
Reports of Product use in unapproved indication with MONGERSEN
22.7%
of all MONGERSEN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product use in unapproved indication From MONGERSEN?
Of the 5 reports.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MONGERSEN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does MONGERSEN Cause?
Drug ineffective for unapproved indication (12)
Off label use (12)
Drug ineffective (10)
Product use issue (5)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)